CD4 and melanoma: Interestingly, MHC class II surface expression on human melanoma cells has been described to be associated with good prognosis [36], suggesting that endogenous tumor antigen-specific CD4+ T cells might become activated by tumor cells and exert their anti-tumor effects directly or indirectly.